IRWD
NASDAQ
$3.91
Ironwood Pharmaceuticals Inc - Class A (IRWD)
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. The company is headquartered in Boston, Massachusetts.
Sector:
Healthcare
Buy
Target: $6.35 (+62.40%)
Market Cap
$658M
Profit Margin
38.3%
P/E Ratio
8.62
Free Cash Flow Yield
17.04%
Price Chart
Valuation
Market Cap$658M
P/E8.62
Forward P/E12.33
P/S1.81
P/B2.59
Profitability
Total Revenue (TTM)$362M
Gross Profit (TTM)$272M
EBITDA$201M
Profit Margin38.3%
Operating Margin68.1%
EPS$0.46
Financial Health
Debt-to-Equity-92%
Free Cash Flow Yield17.04%
Growth & Risk
EPS 5Y CAGR-12.17%
Revenue 5Y CAGR-1.93%
FCF 5Y CAGR-10.65%
Beta (5Y)1.07
Sharpe Ratio2.02